Infection, hospitalization, ICU admission and death due to SARS-CoV-2 in a population cohort

  • Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Total publications:0 publications

Grant number: COV20_00542

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Principal Investigator

    Jesus Castilla Catalán
  • Research Location

    Spain
  • Lead Research Institution

    FUNDACION INSTITUTO DE INVESTIGACION SANITARIA DE NAVARRA
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease transmission dynamics

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Health PersonnelHospital personnel

Abstract

Objective: to estimate the effect of sociodemographic characteristics, chronic diseases and other conditions on risk in infection, hospitalization and severe forms of COVID-19. Methods: Based on healthcare and epidemiological surveillance databases, the population cohort covered by the Health Service (640,000 people) will be constructed. Two sub-cohorts will be defined for specific analyzes: institutionalized people (n = 6000) and health professionals (n = 12,000). The incidence rates of cases with clinical suspicion, of infection confirmed by PCR, of hospitalizations, of ICU admissions, of assisted ventilation and of mortality will be calculated. Lethality will also be calculated in confirmed cases and in hospitalized patients. The predictor variables to be evaluated are sex, age, chronic diseases, pregnancy, obesity, hypertension, smoking, functional capacity, socioeconomic level, number of cohabitants, minors at home and use of services. Antibody seroprevalence will be assessed in a sample of patients from the sentinel network and / or donors.